Related Experiment Video

Updated: May 28, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Re: Radical prostatectomy versus watchful waiting in early prostate cancer

Patrick C Walsh

    The Journal of Urology
    |October 14, 2011
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Retzius-Sparing Robot-Assisted Radical Prostatectomy
    12:10

    Retzius-Sparing Robot-Assisted Radical Prostatectomy

    Published on: May 19, 2022

    Related Experiment Videos

    Last Updated: May 28, 2026

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
    05:19

    A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

    Published on: November 7, 2025

    Retzius-Sparing Robot-Assisted Radical Prostatectomy
    12:10

    Retzius-Sparing Robot-Assisted Radical Prostatectomy

    Published on: May 19, 2022

    Related Concept Videos

    Urinary Tract Calculi VI: Surgical Management01:25

    Urinary Tract Calculi VI: Surgical Management

    Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...

    Articles linked to this work by shared authors, journal, and citation graph.

    Treatment Response and Outcomes of Prostate Cancer Patients Carrying the Germline MMS22L F722fs Mutation.

    The Prostate·2026

    Confirmation of BIK and SAMHD1 as Prostate Cancer Susceptibility Genes.

    The Prostate·2025

    Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN Guidelines.

    The Prostate·2025

    Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate Cancer.

    European urology focus·2025

    Association of rare, recurrent nonsynonymous variants in the germline of prostate cancer patients of African ancestry.

    The Prostate·2022

    A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.

    European urology·2022

    2026 Updates to the Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer: AUA/SUO Guideline.

    The Journal of urology·2026

    Factors and Reasons Influencing Compliance with Post-vasectomy Semen Analysis: A Systematic Review.

    The Journal of urology·2026

    Anastomotic Urethroplasty is Associated with a Lower Risk of Stricture Recurrence Compared to Buccal Mucosa Graft Onlay after Reconstruction for Radiation-Induced Bulbomembranous Urethral Stenosis.

    The Journal of urology·2026

    Non-Muscle Invasive Recurrence and Management During Surveillance in Patients with Muscle-Invasive Bladder Cancer Who Achieve Clinical Complete Response to Neoadjuvant Chemotherapy.

    The Journal of urology·2026

    TESTOSTERONE THERAPY IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER IS NOT ASSOCIATED WITH INCREASED RISK OF DISEASE PROGRESSION.

    The Journal of urology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us